Shingles

References

Citations

1. Whitley RJ (2005). Varicella-zoster virus. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 6th ed., vol. 2, pp. 1780–1786. Philadelphia: Elsevier/Churchill Livingstone.

2. Barnes SD, et al. (2005). Microbial keratitis. In GL Mandell et al., eds., Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases, 6th ed., vol. 1, pp. 1395–1406. Philadelphia: Elsevier/Churchill Livingstone.

3. Gnann JW, Whitley RJ (2002). Herpes zoster. New England Journal of Medicine, 347(5): 340–346.

4. Ashkenazi A, Levin M (2004). Three common neuralgias: How to manage trigeminal, occipital, and postherpetic pain. Postgraduate Medicine, 116(3): 16–48.

5. Dubinsky RM, et al. (2004). Practice parameter: Treatment of postherpetic neuralgia. An evidence-based report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology, 63(6): 959–965.

6. Jung BF, et al. (2004). Risk factors for postherpetic neuralgia in patients with herpes zoster. Neurology, 62(9): 1545–1551.

7. Advisory Committee on Immunization Practices (2008). Prevention of herpes zoster: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Advisory Committee on Immunization Practices. MMWR, 57(Early Release): 1–30. Also available online: http://www.cdc.gov/mmwr/preview/mmwrhtml/rr57e0515a1.htm?s_cid=rr57e0515_e.

Other Works Consulted

• Gilden DH (2008). Acute viral central nervous system diseases. In DC Dale, DD Federman, eds., ACP Medicine, section 11, chap. 16. Hamilton, ON: BC Decker.

• Herpes zoster vaccine (Zostavax) (2006). Medical Letter on Drugs and Therapeutics, 48(1243): 73–74.

• Johnson RW, Dworkin RH (2003). Treatment of herpes zoster and postherpetic neuralgia. BMJ, 326(7392): 748–750.

• Katz J, et al. (2004). Acute pain in herpes zoster and its impact on health-related quality of life. Clinical Infectious Diseases, 39(3): 342–348.

• Pregabalin (Lyrica) for neuropathic pain and epilepsy (2005). Medical Letter on Drugs and Therapeutics, 47(1217): 75–76.

Go to previous section	Go to top of page	Go to next section
Author:	Maria G. Essig, MS, ELS	Last Updated: March 9, 2009
Medical Review:	E. Gregory Thompson, MD - Internal Medicine Alexander H. Murray, MD, FRCPC - Dermatology
© 1995-2010 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated. This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.